A detailed history of Sage Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sage Capital Management, LLC holds 3,389 shares of ABBV stock, worth $679,528. This represents 0.32% of its overall portfolio holdings.

Number of Shares
3,389
Previous 3,382 0.21%
Holding current value
$679,528
Previous $580 Million 15.38%
% of portfolio
0.32%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $1,146 - $1,395
7 Added 0.21%
3,389 $669 Million
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $523,499 - $611,330
3,382 New
3,382 $580 Million
Q1 2024

Jul 31, 2024

SELL
$159.82 - $182.1 $1,438 - $1,638
-9 Reduced 0.27%
3,373 $614 Million
Q4 2023

Jul 31, 2024

SELL
$137.6 - $154.97 $2,201 - $2,479
-16 Reduced 0.47%
3,366 $522 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sage Capital Management, LLC Portfolio

Follow Sage Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Management, LLC with notifications on news.